Terri Vidals
Terri Vidals
Interview with Anigent Chief Product Officer & Managing Partner Charles D'Amato
Interview with Anigent Chief Product Officer & Managing Partner Charles D'Amato
Interview with Anigent Chief Product Officer & Managing Partner Charles D'Amato
Thursday 24th February 2022
Terri Vidals interviews Charles D'Amato about Anigent's innovative drug diversion software and its implementation at Mayo Clinic Arizona.
28 minutes
Informative
Empowering
Thought-provoking
About this podcast
Author:
Terri Vidals
Overview:
Categories:
Innovative Treatments & Recovery Paths
Nutritional Pathways to Recovery
Family Recovery from Addiction
Navigating Intimate Relationships
Recovery Reimagined
Links:
Visit site
Episodes:
128 (View all)
Do you want to link to this podcast?
Get the buttons here!Anigent's Innovative Approach to Drug Diversion: A Conversation with Charles D'Amato
What the difference is is that we're able to actually identify diverters versus just providing a bunch of data to that end user, that auditor, and having them have to go and try to determine who their highest risk individual is.
When it comes to tackling drug diversion in healthcare, innovation is key. In this episode, Terri Vidals sits down with Charles D'Amato, the Chief Product Officer and Managing Partner of Anigent, to discuss their groundbreaking software designed for drug diversion monitoring. Developed by a pharmacist with extensive clinical and operational experience, Anigent's software stands out for its predictive analytics capabilities.
D'Amato shares insights into how the software doesn't just flag potential issues but actually identifies individuals at risk of diverting drugs. He also highlights its successful implementation at Mayo Clinic Arizona, emphasizing the importance of proactive measures and a culture of constant vigilance in preventing drug diversion. If you're a healthcare professional looking to enhance your facility's drug safety protocols, this conversation offers valuable perspectives and practical advice.